Browsing by Author Chapman, M. J.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 15 to 19 of 19 < previous 
TitleAuthor(s)Issue date???itemlist.???
PAF-acetylhydrolase is an antiinflammatory and antioxidant phospholipase A(2) that may be implicated in atherothrombosisTselepis, A. D.; Elisaf, M. S.; Goudevenos, J.; Karabina, S. A.; Tsoukatos, D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Paf-Degrading Acetylhydrolase Is Preferentially Associated with Dense Ldl and Vhdl-1 in Human Plasma - Catalytic Characteristics and Relation to the Monocyte-Derived EnzymeTselepis, A. D.; Dentan, C.; Karabina, S. A. P.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolaseDentan, C.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoproteinTsoukatos, D. C.; Liapikos, T. A.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Reduced HDL levels are a major feature of the dyslipidemia characteristic of juvenile chronic arthritisTselepis, A. D.; Besis, S.; Elisaf, M.; Karabina, S. A. P.; Lapatsanis, P. D.; Chapman, M. J.; Siamopoulou, A.24-Nov-2015-